Evidence map›Paper›PMID 42152475›Full record

ArticleAnnals of transplantation2026

Reduced Cardiovascular Risk Indicated by Changes in Triglyceride-Glucose Index After Pancreas Transplantation.

Paweł Skrzypek, Małgorzata Buksińska-Lisik, Paweł Ziemiański, Antonina Respondek, Kaja Śmigielska, Karol A Sadowski, Justyna Domienik-Karłowicz, Maciej Kosieradzki, Wojciech Lisik

Abstract read
In one paragraph

Article in Annals of transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Paweł SkrzypekDepartment of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.
Małgorzata Buksińska-LisikDepartment of Internal Disease and Cardiology, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-7738-1049
Paweł ZiemiańskiDepartment of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0003-4281-8030
Antonina RespondekDepartment of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.
Kaja ŚmigielskaDepartment of General, Gastroenterology and Oncologic Surgery, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0001-6019-9435
Karol A SadowskiDepartment of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.
Justyna Domienik-KarłowiczDepartment of Internal Medicine & Cardiology with the Center for Management of Venous Thromboembolic Disease, Warsaw, Poland.ORCID 0000-0001-6122-9755
Maciej KosieradzkiDepartment of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0003-2889-1311
Wojciech LisikDepartment of General and Transplantation Surgery, Medical University of Warsaw, Warsaw, Poland.ORCID 0000-0003-3020-3979

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND Pancreas transplantation is the best causal treatment for type I diabetes. The triglyceride-glucose (TyG) index is a validated marker of the long-term risk of cardiovascular episodes. The purpose of this study is to evaluate the potential reduction in cardiovascular risk, using the TyG index as a surrogate marker, in patients undergoing pancreas transplantation. MATERIAL AND METHODS The analysis was conducted on data obtained from 86 patients undergoing pancreas transplantation at the Department of General and Transplantation Surgery, Medical University of Warsaw. Serum triglyceride and glucose levels were recorded at the stage of qualification for transplantation and at 1, 3, 6, and 12 months after transplantation. The repeated measures ANOVA model was applied to the group of patients with complete data (n=14), showing a statistically significant effect of time. The difference between values before and after 12 months was statistically significant. RESULTS The mixed model confirmed the significant effect of time on the TyG index value. The mean TyG index value decreased significantly 1 month after transplantation and remained stable. Trend analysis was performed for the TyG index values at 3 time points: before transplant, early follow-up, and late follow-up. The mean TyG index decreased significantly as early as 1 to 3 months. CONCLUSIONS In this cohort of pancreas transplant recipients, transplantation was strongly associated with a reduction in the TyG index, suggesting a lower long-term risk of cardiovascular events.

Indexed as

Blood GlucoseCardiovascular DiseasesDiabetes Mellitus, Type 1Pancreas TransplantationTriglyceridesAnalysis of VarianceBiomarkersHeart Disease Risk FactorsHumansModels, CardiovascularPostoperative PeriodRetrospective StudiesTreatment OutcomeBiomarkersBlood GlucoseTriglycerides

Identifiers

PMID42152475
PMCPMC13198169

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.